Literature DB >> 9346359

Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1.

G Penton Rol1, N Polentarutti, M Sironi, S Saccani, M Introna, A Mantovani.   

Abstract

Available information suggests that the type II IL-1 receptor (RII) is a nonsignaling molecule which acts as a decoy for IL-1. The decoy function model for RII was supported by gene transfer experiments in fibroblasts and keratinocytes. Therefore, inhibition of IL-1 responsiveness after decoy RII gene transfer could reflect a non-physiological cellular context and receptor number. In the present study, constructs encoding RII or a cytoplasmic deletion mutant (delta 372-398) were transfected into U937 cells which express only low levels of RI detectable by RT-PCR. Gene transfer resulted in receptor numbers (approximately equal to 10(3)/cell) of the same order of magnitude as that found in normal myelomonocytic cells. Transfer of RII or a cytoplasmic deletion mutant into U937 did not increase responsiveness to IL-1, as assessed by IL-8 expression and production; it actually considerably dampened it. These results are consistent with the view that in a myelomonocytic cellular context, RII does not contribute to signaling and represents a unique pathway of negative regulation of the IL-1 system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346359

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  1 in total

1.  Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.

Authors:  Marina K Roell; Hassan Issafras; Robert J Bauer; Kristen S Michelson; Nerissa Mendoza; Sandra I Vanegas; Lisa M Gross; Paul D Larsen; Daniel H Bedinger; David J Bohmann; Genevieve H Nonet; Naichi Liu; Steve R Lee; Masahisa Handa; Seema S Kantak; Arnold H Horwitz; John J Hunter; Alexander M Owyang; Amer M Mirza; John A Corbin; Mark L White
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.